A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines
Clinical trial NCT02108158 · COMPLETED
Trial details
- NCT number
- NCT02108158
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.